Novartis shares experienced a significant decline following disappointing results from the del desiran drug trial, impacting investor confidence.
Read More
The Geo Chronicle
Your Window to World Affairs
Biotech IPO Resurgence Faces Stiff Competition from Big Pharma M&A
Biotech IPOs are cautiously returning, but Big Pharma's aggressive M&A for pipeline replenishment creates intense market competition.
Read More
The Space Race for Pharmaceuticals: Drug Development Shifts to Low Earth Orbit
Discover how microgravity in low Earth orbit is revolutionizing pharmaceutical drug development, accelerating protein crystallization and tissue engineering.
Read MoreYOU MAY HAVE MISSED
